Clinical trial · Observational
A Cohort Study of Uterine Malignancies
NCT05635123CI-TRIAL-00092277recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic markers and prognostic biomarkers.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- progression free survival (PFS)
- timeFrame
- 60 months
- description
- progression free survival for patients with cervical cancer or endometrial cancer
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age 20-75 years; * Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time; * Women attending a health check-up; * Obtain informed consent and sign an informed consent form. Exclusion Criteria: * Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment； * Patients with cancer other than cervical cancer or endometrial cancer; * Women who have received hysterectomy or pelvic radiation therapy previously.
References
Publications (0)
Data not yet available
No reference posted for this study.